Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Tolerability of Interferon-Beta-1a and Estroprogestins Association in MS Patients
The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2005 by S. Andrea Hospital.
Recruitment status was  Recruiting
Study NCT00151801   Information provided by S. Andrea Hospital

First Received on September 8, 2005.   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Multiple Sclerosis
Additional conditions recognized in this trial
Multiple Sclerosis, Relapsing-Remitting
Sclerosis
More general conditions related to this trial
Autoimmune Diseases
Autoimmune Diseases of the Nervous System
Demyelinating Autoimmune Diseases, CNS
Demyelinating Diseases
Immune System Diseases
Nervous System Diseases
Pathologic Processes
Interventions listed in this trial
estroprogestins
interferon-beta 1a
Additional drug interventions recognized in this trial
Ethinyl Estradiol
Interferon beta 1a
Interferon-beta
Interferons
More general drug interventions related to this trial
Adjuvants, Immunologic
Anti-Infective Agents
Antineoplastic Agents
Antiviral Agents
Estrogens
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
S. Andrea Hospital


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services